About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Fibrolipoma of the Rib: A Case Report and Review of the Literature
Shantanu Pande1, Zaeba Nayeem2, Bhagat Singh Lali1, Zachariah Chowdhury1, Deepak Kumar Singh1
1Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malviya Cancer Center, Sunder Bagiya, BHU campus, Varanasi, Uttar Pradesh, India, 221005; 2Tata Memorial Hospital, Dr E Borges Road, Parel, Mumbai, India.
Corresponding Author:
Dr Shantanu S. Pande 
Email: quantnucmed@gmail.com
Received: 22-MAR-2021 Accepted: 22-JUL-2021 Published Online: 05-AUG-2021
DOI: http://dx.doi.org/10.17659/01.2021.0043
Abstract
Background: Fibrolipoma is a rare histological variant of lipoma and although fibrolipomas of the oral cavity have been reported, only a few cases of fibrolipoma of the thoracic region have been published. Case Report: A 49-year-old man presented with pain and a lump in the left side chest. After initial evaluation, CT followed by PET/CT were acquired. The scan findings were suggestive of a benign lipomatous tumor of the left 4th rib; however, malignant transformation could not be ruled out. Hence, excision of the rib lesion with mesh repair and flap reconstruction was performed. Post-operative histopathology was suggestive of a fibrolipoma with absence of atypia or mitosis. Radiological and pathological findings and management of the case are discussed below. Conclusion: Follow-up of such rare tumors are essential to detect recurrence as knowledge about the behavior of these tumors is limited.
Keywords : Lipoma, Male, Pain, Ribs, Surgical Mesh, Thorax.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024